These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8814475)

  • 21. Pulmonary dysfunction following traumatic quadriplegia. Recognition, prevention, and treatment.
    McMichan JC; Michel L; Westbrook PR
    JAMA; 1980 Feb; 243(6):528-31. PubMed ID: 7351783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atelectasis in spinal cord injured people after initial medical stabilization.
    Sugarman B
    J Am Paraplegia Soc; 1985 Jul; 8(3):47-50. PubMed ID: 3842981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cause of death for patients with spinal cord injuries.
    DeVivo MJ; Kartus PL; Stover SL; Rutt RD; Fine PR
    Arch Intern Med; 1989 Aug; 149(8):1761-6. PubMed ID: 2669663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atelectasis and pneumonia in acute spinal cord injury.
    Fishburn MJ; Marino RJ; Ditunno JF
    Arch Phys Med Rehabil; 1990 Mar; 71(3):197-200. PubMed ID: 2317137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
    Shak S; Capon DJ; Hellmiss R; Marsters SA; Baker CL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9188-92. PubMed ID: 2251263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory complications and management of spinal cord injuries.
    Mansel JK; Norman JR
    Chest; 1990 Jun; 97(6):1446-52. PubMed ID: 2189697
    [No Abstract]   [Full Text] [Related]  

  • 27. Pus, deoxyribonucleic acid, and sputum viscosity.
    Picot R; Das I; Reid L
    Thorax; 1978 Apr; 33(2):235-42. PubMed ID: 26989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative atelectasis.
    Massard G; Wihlm JM
    Chest Surg Clin N Am; 1998 Aug; 8(3):503-28, viii. PubMed ID: 9742334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The respiratory system in spinal cord injury.
    Lanig IS; Peterson WP
    Phys Med Rehabil Clin N Am; 2000 Feb; 11(1):29-43, vii. PubMed ID: 10680156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary management following acute SCI.
    Lucke KT
    J Neurosci Nurs; 1998 Apr; 30(2):91-104. PubMed ID: 9642617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peri-operative atelectasis and alveolar recruitment manoeuvres].
    Rama-Maceiras P
    Arch Bronconeumol; 2010 Jun; 46(6):317-24. PubMed ID: 19959274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary atelectasis: a pathogenic perioperative entity.
    Duggan M; Kavanagh BP
    Anesthesiology; 2005 Apr; 102(4):838-54. PubMed ID: 15791115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase.
    Voelker KG; Chetty KG; Mahutte CK
    Intensive Care Med; 1996 Jun; 22(6):582-4. PubMed ID: 8814475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory care of patients with cervical spinal cord injury: a review.
    Arora S; Flower O; Murray NP; Lee BB
    Crit Care Resusc; 2012 Mar; 14(1):64-73. PubMed ID: 22404065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recombinant human DNase in conditions other than cystic fibrosis].
    Kristensen K
    Ugeskr Laeger; 2010 Feb; 172(8):616-9. PubMed ID: 20184817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S
    Chest; 1995 Feb; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.